Abstract
Older agents are just as good as newer ones for improving quality of life in schizophrenia patients, reports a British study that compared first- and second-generation antipsychotic agents over a one-year course of therapy. These results, published in the October 2006 issue of Archives of General
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
